Labshake search
Citations for Tocris :
551 - 600 of 1908 citations for 6H Pyrazolo 3 4 b pyridin 6 one 3 cyclobutyl 1 2 4 5 tetrahydro 4 methyl 9CI since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2021Quote: ... Hox propagation was initiated by activation of Wnt signaling using NMP media comprised of E6 medium supplemented with 200 ng/mL FGF8b and 3 μM CHIR99021 (Tocris). This constitutes the “Hox timepoint” of 0hrs ...
-
bioRxiv - Pharmacology and Toxicology 2021Quote: ... 0.3 or 1 mg/kg of the mGlu2/3 receptor agonist LY379268 (Cat No.: 2453, Batch No.: 9B/232416, CAS No.: 191471-52-0, Tocris Bioscience ...
-
bioRxiv - Neuroscience 2022Quote: ... 4-[2-Phenyl-5,7-bis(trifluoromethyl)pyrazolol[1,5-a]pyrimidin-3-yl]phenol (PHTPP, 10 μM dissolved in 10% DMSO, TOCRIS, Minneapolis, MN), microinjected bilaterally into the CeA (0.5 μL over one minute with a one-minute wait post-infusion ...
-
bioRxiv - Cell Biology 2023Quote: iPSCs were first differentiated into iAT2s and passaged as above in 3D cultures in iAT2 medium (CK+DCI) supplemented for the first 3 days after passaging with 10 uM Y-27632 (Tocris). To generate iAT1s ...
-
bioRxiv - Neuroscience 2023Quote: ... Extracellular action potentials were recorded in 3 independent cultures for either genotype in the presence of 50nM nifedipine (Tocris Bioscience) or vehicle using the MaestroPro (Axion Biosystems ...
-
bioRxiv - Bioengineering 2023Quote: ... The media were changed at day 3 to remove the ROCK inhibitor and to add 10 µM DAPT (Tocris Bioscience), which remained until day 7 ...
-
Synaptic and intrinsic potentiation in O-LM interneurons is induced by theta patterns of stimulationbioRxiv - Neuroscience 2022Quote: ... chelerythrine chloride (1,2-Dimethoxy-12-methyl[1,3]benzodioxolo[5,6-c]phenanthridinium chloride) were obtained from Tocris and PIP2 (phosphatidylinositol-4,5-bisphosphate ...
-
bioRxiv - Pharmacology and Toxicology 2019Quote: ... or 2 mM (R,S)-3,5-DHPG (mGlu1/5 agonist, Tocris 0805 and 0342 respectively), and the astrocyte marker Sulforhodamine 101 (40 μM ...
-
bioRxiv - Neuroscience 2021Quote: ... 25 μM of d-(-)-2-amino-5-phosphonopentanoic acid (D-AP5, 0106, Tocris Bioscience, UK), and 10 μM of SR95531 (SR ...
-
bioRxiv - Neuroscience 2019Quote: ... D-2-amino-5-phosphonovalerate (“D-AP5”, 50 mM in PBS, Tocris Cat No 0106); Retigabine (100 mM in DMSO ...
-
HOIL-1L deficiency induces cell cycle alteration which causes immaturity of myocyte and fibrogenesisbioRxiv - Cell Biology 2023Quote: ... the medium was replaced with differentiation medium containing 5 μM IWP-2 (TOCRIS, Cat.# 3533), a Wnt inhibitor ...
-
bioRxiv - Neuroscience 2024Quote: ... BIBP-3226 (Y1 receptor antagonist, 1-2 μM), and BIIE-0246 (Y2 receptor antagonist, 1-2 μM) were obtained from Tocris.
-
bioRxiv - Developmental Biology 2021Quote: ... CHIR99021 (6 μM; Tocris), FGF2 (20 ng/mL ...
-
bioRxiv - Neuroscience 2020Quote: ... while the ones on the other membrane were treated with tetrodotoxin (TTX, 1 hour, 500 nM, Tocris) or apamin (1 hour ...
-
bioRxiv - Cell Biology 2020Quote: ... and diabetic NOD mice (14-26 weeks; n=3) were intra-peritoneally injected with 50mg/kg of Chloroquine diphosphate (Tocris #4109). Two hours post injection ...
-
bioRxiv - Cell Biology 2020Quote: ... into fibronectin-coated wells of two 96 well plates per biological replicate to assess proliferation on day 0 (D0) and day 3 (D3) in the presence or absence of 10 μM RARβ antagonist LE135 (Tocris Bioscience) using the cell viability MTS assay ...
-
bioRxiv - Cancer Biology 2021Quote: ... Pladienolide B and SRPIN340 were purchased from Tocris.
-
bioRxiv - Cell Biology 2022Quote: ... Conduritol B epoxide (CBE) was procured from Tocris Bioscience ...
-
bioRxiv - Biochemistry 2023Quote: ... B-HT 933 dihydrochloride (α2 adrenergic agonist, TOCRIS), DL-isoproterenol hydrochloride (non-selective β adrenergic agonist ...
-
bioRxiv - Cell Biology 2023Quote: ... or 60 nM latrunculin B (Tocris, Bristol, UK) for 2 h prior to experiments ...
-
bioRxiv - Neuroscience 2022Quote: ... the medium was replaced with HBSS containing 6-N,N-Diethyl-β-γ-dibromomethylene-D-adenosine-5′-triphosphate (ARL 67156; Tocris, 1283) at a concentration of 100 μM ...
-
bioRxiv - Cell Biology 2020Quote: ... N2B27 (1-5% KSR) base media was supplemented with 1 µM PD0325901 (Tocris 4192); 3 µM CHIR99021 (Tocris 4423) ...
-
bioRxiv - Neuroscience 2021Quote: ... n=20) group were randomized to receive either saline or GLP-1R antagonist Exendin-3(9-39)amide (Ex-9) (Tocris Bioscience, UK) (85 μg/kg dissolved in saline ...
-
bioRxiv - Genomics 2022Quote: ... iPS cells were grown to 80– 90% confluence and changed into CM Media supplemented with 3 μM CHIR99021 (Tocris Biosciences, Bristol, UK) for 2 days ...
-
bioRxiv - Cancer Biology 2022Quote: ... Proteins were then transferred onto PVDF membranes (Cytiva, Catalog #: 10600023) using a wet transfer approach and membranes were then blocked with 3% bovine serum albumin (Tocris, Catalog #: 5217) and probed for CDC42 (Cell Signaling Technology ...
-
bioRxiv - Genomics 2020Quote: ... supplemented with SMAD inhibitors (DMH-1 2 μM Tocris, Cat. ...
-
bioRxiv - Neuroscience 2022Quote: ... and PACAP(6-38) (Tocris). For high K+ stimulation ...
-
bioRxiv - Neuroscience 2022Quote: ... and 6-OHDA (2547, Tocris) were injected into the left hemisphere of substantia nigra pars compacta (SNpc ...
-
bioRxiv - Neuroscience 2023Quote: ... 6-OHDA hydrobromide (Tocris Bioscience) was dissolved in ice-cold 0.02% ascorbic acid dissolved in saline to a concentration of 4 μg/μl ...
-
bioRxiv - Cell Biology 2022Quote: We used the following drugs: centrinone B (Tocris Bioscience), nocodazole (Sigma) ...
-
bioRxiv - Cancer Biology 2020Quote: ... 0.5µM TGF-b inhibitor A-83-01 (TOCRIS 2939), 0.05µg/mL EGF (Thermo Fisher PMG8041) ...
-
bioRxiv - Genomics 2022Quote: ... and 3μm GSK3a/b inhibitor (CHIR99021) (Tocris, Cat#: 4423). Prior to genomic DNA extraction ...
-
bioRxiv - Genomics 2023Quote: ... and the GABA-B receptor antagonist CGP55845 (Tocris #1246). Experiments with a series resistance of >15 MΩ or >20% change in series resistance were excluded from the final dataset ...
-
bioRxiv - Microbiology 2023Quote: ... destruxin B and gymnoascolide A were purchased from Tocris, Santa Cruz Biotechnology ...
-
Sexual differences in neuronal and synaptic properties across subregions of the mouse insular cortexbioRxiv - Neuroscience 2023Quote: ... and L-APV 50 μM (DL-2-Amino-5-phosphonopentanoic acid, a selective NMDA receptor antagonist, Tocris).
-
bioRxiv - Neuroscience 2022Quote: ... cells were incubated for 1 h with 5 µM GsMTx4 (Tocris) or 15 and 30 min with 1 µM soluble Aβ1-42 (Bachem ...
-
bioRxiv - Cell Biology 2020Quote: ... Torin 1 (Tocris, 4247, 250 nM in DMSO, 2 hrs), Bortezomib (LC Labs B-1408 ...
-
bioRxiv - Physiology 2021Quote: ... CHO-K1 cells were transfected with cDNAs encoding for hFGF23-V5 and PCs in the ratio of 5:1 and 24 hours later pretreated for 5 hours with Dec-RVKR-CMK (50 μM; Tocris) or D6R (20 μM ...
-
bioRxiv - Cell Biology 2021Quote: ... B/D medium was supplemented during submerged culture with 1 nM EC23 (light-stable retinoic acid receptor agonist; Tocris, Abingdon, UK). After confluence was reached ...
-
bioRxiv - Neuroscience 2020Quote: ... and N,N,H,-Trimethyl-5-[(tricyclo[3.3.1.13,7]dec-1-ylmethyl)amino]-1-pentanaminiumbromide hydrobromide (IEM-1460, Tocris) were prepared as 10 mM stocks dissolved in distilled water ...
-
bioRxiv - Neuroscience 2020Quote: ... 250 nM PACAP 6-38 (Tocris), 20 µM Bicuculline (Cayman chemical) ...
-
bioRxiv - Neuroscience 2019Quote: ... 6-OHDA (Tocris; conjugated with HBr) was injected bilaterally in a 4 × 3 grid at AP coordinates 5.1 ...
-
Interactions with stromal cells promote a more oxidized cancer cell redox state in pancreatic tumorsbioRxiv - Cancer Biology 2020Quote: ... 0.5 μM TGF-b inhibitor A-83-01 (TOCRIS 2939), 0.05 μg/mL EGF (Thermo Fisher PMG8041) ...
-
bioRxiv - Neuroscience 2021Quote: ... 8 μM Dihydro-b-erythroidine hydrobromide (DHβE; Tocris, Cat#2349); 10 μM SR 9551 hydrobromide (gabazine ...
-
bioRxiv - Neuroscience 2021Quote: ... Drug-evoked locomotor-like activities were induced by bath-applying 10 to 14 µM of N-methyl- D-aspartate (NMDA, Tocris) and serotonin (5-HT ...
-
bioRxiv - Neuroscience 2020Quote: ... N-methyl D-aspartate (NMDA) receptors were blocked by the non-competitive NMDA receptor antagonist MK-801 (Tocris; 100 μM), co-applied with the competitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid AMPA/kainate receptor antagonist CNQX (Tocris ...
-
bioRxiv - Neuroscience 2021Quote: ... glutamate and GABA receptor blockers (10 μM NBQX, Tocris, UK, 1044; 5 μM CPP, Tocris, 0247; 5 μM SR-95531, Tocris, 1262; 1 μM CGP-55845, Tocris, 1248) were included in the recording solutions.
-
bioRxiv - Bioengineering 2022Quote: ... and Nodal/Activin inhibitor (SB431542, Tocris, 1614, 5 µM, days 1-10). On day 2 ...
-
bioRxiv - Neuroscience 2019Quote: ... To block NMDA receptors we used D- (-)-2-Amino-5-phosphonopentanoic acid (D-AP5, Tocris, 10 μM final concentration). To block glycinergic inhibition ...
-
bioRxiv - Neuroscience 2020Quote: ... 20 μM 6,7-dinitroquinoxaline-2,3-dione (DNQX) and 20 μM D-(-)-2-amino-5-phosphopentanoic acid (D-AP5) (Tocris Bioscience) to block glycine- ...